Gemfibrozil cholesterol lowering intervention
systematic review meta-analysis network meta-analysis
 

Ausgem - ApoGemfibrozil - Apo Gemfibrozil - Apo-Gemfibrozil - SBPA Gemfibrozil - Pilder - Lipur - Lopid R - Lopid - Litarek - Lipox Gemfi - Lipazil - Jezil - Healthsense Gemfibrozil - GenRX Gemfibrozil - GenGemfibrozil - Gen Gemfibrozil - Gen-Gemfibrozil - Gemhexal - Gemfibrozilo Ur - Gemfi 1A Pharma - Decrelip - Trialmin - DBL Gemfibrozil - CI719 - CI 719 - CI-719 - Bolutol - Gemfibrosil - Gemfibrozil      

Select             pdf
Filter

  • Group by...
Trial Studied trt Control trt patientstagsROB Trial resultAll cause deathCoronary death

atrial fibrillation  

VA HIT (AF ancillary study), 1999       gemfibrozilplaceboLow risk of bias negative

cardiovascular prevention  

VA-HIT, 1999      NCTgemfibrozilplaceboLow risk of bias suggesting-10%-21%
Helsinki (HHS), 1987   gemfibrozilplaceboLow risk of bias suggesting2%-27%
HHS (Frick)(secondary prev subgroup), 1993   gemfibrozilplaceboExploratory negative61%
HHS (diabetic sub group), 1987   gemfibrozilplacebodiabetic patients primary prevention Low risk of bias -
VA-HIT (diabetic sub group), 1999     gemfibrozilplacebodiabetic patients secondary prevention Low risk of bias negative
LOCAT, 1997     gemfibrozilplaceboExploratory negative

diabetes type 2  

HHS (diabetic sub group), 1987   gemfibrozilplacebodiabetic patients primary prevention Low risk of bias -
VA-HIT (diabetic sub group), 1999     gemfibrozilplacebodiabetic patients secondary prevention Low risk of bias negative

post myocardial infarction  

VA-HIT, 1999      NCTgemfibrozilplaceboLow risk of bias suggesting-10%-21%



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons